Why These 5 Stocks Are Trending on Monday

2. Autolus Therapeutics plc (NASDAQ:AUTL) shares have surged 26.5% after a fund managed by Blackstone, Blackstone Life Sciences, agreed to invest up to $250 million in the company. Of the total, up to $150 million will be used to help Autolus Therapeutics plc (NASDAQ:AUTL) develop and commercialize its leukemia therapy treatments. Blackstone Life Sciences has also agreed to purchase $100 million of Autolus Therapeutics plc (NASDAQ:AUTL)’s stock. Citadel Investment Group was long 2,762,754 shares of Autolus Therapeutics plc (NASDAQ:AUTL) at the end of June.